English
Language disorders and focal epilepsy are common neurological disorders with major medical, educational and socio-economical disturbances. Moreover, how the language cortex develops and functions represents a crucial scientific issue. Our project aims at understanding the various and related developmental disorders of the speech cortex and circuits, at bridging clinical, genetic, molecular, functional and electrophysiological gaps between such disorders, and at modifying the brain developmental programs the corresponding proteins are involved in. While progress in the analysis of the speech networks has been made through neuroimaging, little is known at the molecular level. We and others have identified a few genes and pathways in the recent years and our most recent and unpublished data demonstrate the existence of a FOXP2-SRPX2/uPAR regulatory link that is altered in speech disorder, and a role for rat Srpx2 (Sushi-Repeat Protein) in neuronal migration during brain cortical development. These data represent key entries to address several crucial scientific issues: i/further identify and study the molecular pathways for the spectrum of brain disorders variably associating focal epilepsy, speech impairment, and altered development of the speech areas and networks : rolandic epilepsy, verbal dyspraxia, continuous spike-wave during slow sleep syndrome, perisylvian polymicrogyria,…; ii/make links between such phenotypes without any detectable brain anomaly and those with developmental defects, by studying the involvement of molecular pathways such as Srpx2 in brain cortical development; iii/study the generation of neuronal networks in the context of in utero alteration of this pathway; iv/test the possibility of rescuing the phenotype of impaired neuronal migration after birth in a conditional way; v/appreciate the influence of nongenetic factors such as drugs and viruses, on the phenotypes created by genetic alteration of this pathway. A highly complementary combination of advances in genomics, molecular and cell biology, neurobiology, and neurophysiology must be employed by several partners with specific expertises. The project is organized in several tasks that each will address specific issues. We will: study the clinical, genetic and genomic overlaps between various disorders of the speech areas and networks; identify regulatory and functional molecular links between the above related disorders; decipher the role of Srpx2 in the development of the rat brain cortex by RNA interference in utero, determine how do the SRPX2 mutations interfere with the regular pattern of neuronal migration, and test whether the phenotype can be rescued by conditional expression of Srpx2 after birth; investigate for any early alteration in the cortical neuronal functioning and network organization caused by Srpx2 silencing in utero and dissect the mechanisms underlying the generation of aberrant patterns by misplaced neurons; address the general question of the possible influence and/or use of environmental factors (drugs, viruses) during pregnancy on the neuronal migration defects of genetic origin. Starting from previous data that constitute crucial key points, we expect our results to be important in the fields of those epilepsies with language deficits and of the speech disorders, and of the anomalies of cortical development. The way aberrant networks are generated by misplaced neurons is also a crucial and fundamental issue. Generally testing the influence of non-genetic (environmental) factors such as drugs and viruses on the in utero phenotypes obtained by alteration of a given gene (here, Srpx2) will also represent an important key step towards a better understanding on the respective relationship between environmental and genetic factors during pregnancy. Finally, conditional rescue by Srpx2, a secreted protein, will provide a proof-of-concept towards the future design of specific therapeutic strategies.
